Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

CH-Auto Challenges Li Auto, Nio, Xpeng with U.S. SPAC Listing

Key takeaways:

Benzinga

Achilles Therapeutics Doses First Patient with Higher-dose cNeT in CHIRON Phase 1/2a Trial for Advanced NSCLC

Achilles Therapeutics plc (NASDAQ: ACHL) announced that the first patient has been dosed with personalized clonal neoantigen-reactive T cells, or cNeT, manufactured with the Company's higher-dose VELOS™ Process 2 in the ongoing Phase I/IIa CHIRON clinical trial for the treatment of advanced non-small cell lung can

Benzinga

Why LogicBio Therapeutics Shares Are Popping Off Today

LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmaloni

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Preview: comScore's Earnings

comScore (NASDAQ:SCOR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that comScore will report an earnings per share (EPS) of $-0.14.

Benzinga

Preview: RumbleON's Earnings

RumbleON (NASDAQ:RMBL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that RumbleON will report an earnings per share (EPS) of $0.99.

Benzinga

Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) secured a $250 million term loan facility from Hercules Capital Inc (NYSE:HTGC), providing additional funding to support the expanded clinical program and ramp-up for a potential US launch of resmetirom. The company drew $50 million from the facility at closing and can draw a further $200 million under the agreement. Related…

Benzinga

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults

Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on autistic adults.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

A Preview Of Cronos Group's Earnings

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.08.

Benzinga

4 Analysts Have This to Say About Tabula Rasa HealthCare

Over the past 3 months, 4 analysts have published their opinion on Tabula Rasa HealthCare (NASDAQ:TRHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where Trade Desk Stands With Analysts

Analysts have provided the following ratings for Trade Desk (NASDAQ:TTD) within the last quarter:

Benzinga

Check Out What Whales Are Doing With CRWD

A whale with a lot of money to spend has taken a noticeably bearish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 14 strange trades.

Benzinga

Recap: Ballard Power Systems Q1 Earnings

Ballard Power Systems (NASDAQ:BLDP) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Looking At Marvell Tech's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Marvell Tech. Looking at options history for Marvell Tech (NASDAQ:MRVL) we detected 10 strange trades.

Benzinga

A Preview Of Fox's Earnings

Fox (NASDAQ:FOXA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Fox will report an earnings per share (EPS) of $0.88.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

Mid-Morning Market Update: Markets Open Lower; Tyson Foods Beats Q2 Views

U.S. stocks opened lower this morning, with the Dow Jones tumbling more than 300 points on Monday.

Benzinga

Analyst Ratings for GLOBALFOUNDRIES

GLOBALFOUNDRIES (NASDAQ:GFS) has observed the following analyst ratings within the last quarter:

Benzinga

Why BioNTech Stock Is Rising Today

BioNTech SE (NASDAQ: BNTX) shares are trading higher Monday after the company reported financial results and reaffirmed its 2022 outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Actelis Networks, Inc. To Start Trading Tomorrow

Actelis Networks, Inc. (NASDAQ:ASNS) IPO will take place May, 10 on the NASDAQ exchange under the ticker ASNS. The company is offering shares at an expected price between $4.00 and $6.00 per share with an insider lock-up period of 180 days ending on November 06, 2022.

Benzinga

Why Lordstown Motors Shares Are Sliding Today

Lordstown Motors Corp (NASDAQ:RIDE) reported a first-quarter FY22 loss per share of $(0.46), in line with the consensus of $(0.46) and against a loss of $(0.72) last year. The total operating expenses declined 17.3% Y/Y to $87.9 million. The operating loss incurred for the quarter was $(87.88) million versus $(106.21) million last…

Benzinga

Akoustis Technologies Earnings Perspective: Return On Invested Capital

According to data from Benzinga Pro, during Q3, Akoustis Technologies's (NASDAQ:AKTS) reported sales totaled $4.61 million. Despite a 2.76% increase in earnings, the company posted a loss of $14.82 million.

Benzinga

Saia Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Saia (NASDAQ:SAIA) earned $79.42 million, a 7.68% increase from the preceding quarter. Saia also posted a total of $661.22 million in sales, a 7.15% increase since Q4.

Benzinga

ZoomInfo Technologies's Return on Invested Capital Insights

According to Benzinga Pro data ZoomInfo Technologies (NASDAQ:ZI) posted a 95.73% decrease in earnings from Q4. Sales, however, increased by 8.73% over the previous quarter to $241.70 million.

Benzinga

NXP Semiconductors Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, NXP Semiconductors (NASDAQ:NXPI) earned $666.00 million, a 9.18% increase from the preceding quarter. NXP Semiconductors also posted a total of $3.14 billion in sales, a 3.19% increase since Q4.

Benzinga

Looking Into Avis Budget Group's Return On Invested Capital

Pulled from Benzinga Pro data, Avis Budget Group (NASDAQ:CAR) posted Q1 earnings of $527.00 million, an increase from Q4 of 38.32%. Sales dropped to $2.43 billion, a 5.33% decrease between quarters.

1 … 560 561 562 563

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.